青山紙業(600103.SH):股東方懷月累計減持1895.876萬股 持股跌至5%以下
格隆匯1月20日丨青山紙業(600103.SH)公佈,公司於2019年9月30日披露,公司持股5%以上非第一大股東方懷月擬通過上海證券交易所交易系統以集中競價或大宗交易方式減持公司股份,減持數量不超過1.32億股,即減持不超過公司股份總數的5.7334%,全部為無限售條件流通股。
2020年1月20日,公司收到方懷月先生髮來的《告知函》及《簡式權益變動報告書》,截止本公告日,方懷月通過集中競價交易方式累計減持公司股份1895.876萬股,佔公司總股本的0.8222%。減持後,方懷月持有公司股份1.13億股,佔公司總股本的4.9112%,方懷月不再是公司持股5%以上的股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.